Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim for febrile neutropenia in advanced breast cancer
NCT00035594Phase 3Completed
- Sponsor
- Amgen
- Start
- Feb 2002
- Primary completion
- Feb 2004
01
Overview
A Phase 3 trial of pegfilgrastim in neutropenia, sponsored by Amgen. Started Feb 2002; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00035594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035594.